Suppr超能文献

使用胰岛素泵治疗的 1 型糖尿病患者需要广泛的基础率谱,从微不足道到明显的日间变化不等。

Patients with Type 1 Diabetes Treated with Insulin Pumps Need Widely Heterogeneous Basal Rate Profiles Ranging from Negligible to Pronounced Diurnal Variability.

机构信息

Diabetes Division, Katholisches Klinikum Bochum, St. Josef-Hospital, Klinikum der Ruhr-Universität Bochum, Germany.

Diabeteszentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany.

出版信息

J Diabetes Sci Technol. 2021 Nov;15(6):1262-1272. doi: 10.1177/1932296820949939. Epub 2020 Aug 18.

Abstract

BACKGROUND

Pump-treated patients with type 1 diabetes have widely differing basal insulin infusion profiles. We analyzed consequences of such heterogeneity for glycemic control under fasting conditions.

METHODS

Data from 339 adult patients with type 1 diabetes on insulin pump therapy undergoing a 24-hour fast (basal rate test) were retrospectively analyzed. Hourly programmed basal insulin infusion rates and plasma glucose concentrations as well as their proportions within, below, or above arbitrarily defined target ranges were assessed for specific periods of the day (eg, 1-7 hours, "dawn" period, 16-19 hours, "dusk" period, reference period 20-1 hours/10-14 hours), by tertiles of a predefined "dawn" index (mean basal insulin infusion rate during the "dawn" divided by the reference periods).

RESULTS

The "dawn" index varied interindividually from 0.7 to 4.4. Basal insulin infusion profiles exhibited substantial differences ( = .011), especially overnight. Despite higher insulin infusion rates at 4 and 6.45 hours, patients with the most pronounced "dawn" phenomenon exhibited higher plasma glucose concentrations at those time points ( < .012). Patients with a marked "dawn" phenomenon exhibited a lower probability for low (<4.4 mmol/L) and a higher probability of high values (>7.2 mmol/L) during the dawn period (all values <.01).

CONCLUSIONS

We observe substantial interindividual heterogeneity in the "dawn" phenomenon. However, widely different empirically derived basal insulin infusion profiles appear appropriate for individual patients, as indicated by similar plasma glucose concentrations, mainly in the target range, during a 24-hour fasting period.

摘要

背景

接受胰岛素输注泵治疗的 1 型糖尿病患者的基础胰岛素输注模式存在很大差异。我们分析了这种异质性对空腹状态下血糖控制的影响。

方法

回顾性分析了 339 名接受胰岛素输注泵治疗的 1 型糖尿病成年患者的 24 小时禁食(基础率测试)数据。评估了特定时间段(例如,1-7 小时,“黎明”期,16-19 小时,“黄昏”期,参考期 20-1 小时/10-14 小时)内的每小时编程基础胰岛素输注率和血浆葡萄糖浓度,以及它们在任意定义的目标范围内的比例,并根据预设的“黎明”指数(“黎明”期间的平均基础胰岛素输注率除以参考期)的三分位数进行评估。

结果

“黎明”指数在个体间差异很大,从 0.7 到 4.4。基础胰岛素输注模式存在显著差异(=0.011),尤其是在夜间。尽管在 4 小时和 6.45 小时时胰岛素输注率较高,但“黎明”现象最明显的患者在这些时间点的血浆葡萄糖浓度更高(<0.012)。“黎明”现象明显的患者在“黎明”期出现低血糖(<4.4mmol/L)的可能性较低(<0.01),出现高血糖(>7.2mmol/L)的可能性较高(<0.01)。

结论

我们观察到“黎明”现象存在显著的个体间异质性。然而,从经验中得出的差异很大的基础胰岛素输注模式似乎适合个体患者,这表明在 24 小时禁食期间,患者的血糖浓度主要在目标范围内相似。

相似文献

4
Prediction of Individual Basal Rate Profiles From Patient Characteristics in Type 1 Diabetes on Insulin Pump Therapy.
J Diabetes Sci Technol. 2021 Nov;15(6):1273-1281. doi: 10.1177/1932296820972691. Epub 2020 Nov 30.
6
Initial Basal and Bolus Rates and Basal Rate Variability During Pump Treatment in Children and Adolescents.
J Clin Res Pediatr Endocrinol. 2021 Jun 2;13(2):198-203. doi: 10.4274/jcrpe.galenos.2020.2020.0171. Epub 2020 Dec 30.
9
Spontaneous and transient predinner hyperglycemia in some patients with diabetes: Dusk phenomenon.
Medicine (Baltimore). 2016 Nov;95(47):e5440. doi: 10.1097/MD.0000000000005440.

引用本文的文献

1
Hepatomegaly in an Adult With Type 1 Diabetes Mellitus: Mauriac Syndrome Still Exists in a Developed Country.
JCEM Case Rep. 2025 Apr 15;3(5):luaf070. doi: 10.1210/jcemcr/luaf070. eCollection 2025 May.
6
Insulin Titration Guidelines for Patients With Type 1 Diabetes: It Is About Time!
J Diabetes Sci Technol. 2023 Jul;17(4):1066-1076. doi: 10.1177/19322968221087261. Epub 2022 Apr 2.
7
Prediction of Individual Basal Rate Profiles From Patient Characteristics in Type 1 Diabetes on Insulin Pump Therapy.
J Diabetes Sci Technol. 2021 Nov;15(6):1273-1281. doi: 10.1177/1932296820972691. Epub 2020 Nov 30.

本文引用的文献

2
6. Glycemic Targets: .
Diabetes Care. 2019 Jan;42(Suppl 1):S61-S70. doi: 10.2337/dc19-S006.
3
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.
Lancet. 2018 Oct 13;392(10155):1321-1329. doi: 10.1016/S0140-6736(18)31947-0. Epub 2018 Oct 3.
4
Clinical diagnosis for dusk phenomenon of diabetes.
Medicine (Baltimore). 2018 Aug;97(34):e11873. doi: 10.1097/MD.0000000000011873.
5
Automatic Adaptation of Basal Insulin Using Sensor-Augmented Pump Therapy.
J Diabetes Sci Technol. 2018 Mar;12(2):282-294. doi: 10.1177/1932296818761752.
7
Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes.
Diabetes Technol Ther. 2017 Feb;19(2):109-114. doi: 10.1089/dia.2016.0332. Epub 2016 Dec 21.
8
Spontaneous and transient predinner hyperglycemia in some patients with diabetes: Dusk phenomenon.
Medicine (Baltimore). 2016 Nov;95(47):e5440. doi: 10.1097/MD.0000000000005440.
9
Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
JAMA. 2016 Oct 4;316(13):1407-1408. doi: 10.1001/jama.2016.11708.
10
Rapid Benefits of Structured Optimization and Sensor-Augmented Insulin Pump Therapy in Adults With Type 1 Diabetes.
J Diabetes Sci Technol. 2017 Jan;11(1):180-181. doi: 10.1177/1932296816654715. Epub 2016 Jul 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验